159 related articles for article (PubMed ID: 25278411)
1. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2014 Oct; 42(10):1130-2. PubMed ID: 25278411
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
3. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
4. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
[TBL] [Abstract][Full Text] [Related]
5. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
[TBL] [Abstract][Full Text] [Related]
6. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
[TBL] [Abstract][Full Text] [Related]
10. Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion.
Monzillo V; Corona S; Lanzarini P; Dalla Valle C; Marone P
New Microbiol; 2012 Apr; 35(2):175-82. PubMed ID: 22707130
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
13. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
[TBL] [Abstract][Full Text] [Related]
15. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
16. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
Sheng WH; Ko WJ; Wang JT; Chang SC; Hsueh PR; Luh KT
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
[TBL] [Abstract][Full Text] [Related]
18. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients.
George SJ; Vuddamalay P; Boscoe MJ
Eur J Anaesthesiol; 1997 Jul; 14(4):428-31. PubMed ID: 9253572
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
